Lazard Asset Management’s Transmedics TMDX Stock Holding History
Bought
Maintained
Sold
Other funds holding TMDX
NAMI
HRCM
B
Lazard Asset Management's TMDX Position: Q2 2026 in Review
Lazard Asset Management increased its Transmedics (TMDX) stake by 43% in Q2 2026, buying an estimated $2.35M and bringing the position to 92,549 shares worth $6.15M. The position accounts for 0.01% of the portfolio, ranked #558.
Lazard Asset Management first reported a position in TMDX in Q1 2021 and has held it in 16 quarters since. The position peaked at $7.92M in Q3 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.
- Lazard Asset Management held 92,549 shares of Transmedics worth $6.15M as of Q2 2026.
- Lazard Asset Management bought 27,755 Transmedics shares in Q2 2026, an estimated $2.35M.
- Transmedics made up 0.01% of Lazard Asset Management's portfolio in Q2 2026, its #558 holding.
- Lazard Asset Management first reported a position in Transmedics in Q1 2021 and has held it in 16 quarters since.
- Lazard Asset Management's Transmedics position peaked at $7.92M in Q3 2025.
- 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.
Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.